Clinical Trials Logo

Hydrocephalus clinical trials

View clinical trials related to Hydrocephalus.

Filter by:

NCT ID: NCT02263235 Terminated - Parkinson Disease Clinical Trials

In Vivo Alzheimer Proteomics

PROMARA
Start date: October 8, 2013
Phase: N/A
Study type: Interventional

In France, an estimated 860 000 patients are affected by Alzheimer Disease (AD) which represents, as in other developed countries, a major public health issue. In many cases, AD diagnosis is uncertain and its clinical evolution unpredictable. The exactitude of the diagnosis is however particularly important in the perspective of the validation and use of new therapeutic strategies in AD. Detection of cerebrospinal fluid (CSF) diagnosis biomarkers fell short in the detection, of atypical/mixed cases, of some differential diagnosis, and in differentiating rapid or slow clinical evolutions. Hence, CSF analysis gives a unique opportunity to detect and validate biomarkers in many neurological disorders. Nevertheless, in medical practice, CSF biological analysis is currently limited to a small number of analytes.Quantitative and targeted mass spectrometry, especially operated in the Multiple reaction monitoring mode (MRM), represents an alternative to immunodetection and could be used to detect specific biomarkers in complex matrices such as plasma by specifically discriminating the proteotypic peptides corresponding to each proteins. Mass spectrometry has also the ability to distinguish and quantify isotopically labelled and unlabeled selected targets. This ability was used in a publication by the group of R. Bateman (Washington University, St Louis, USA) who could, after administering stable isotope-labelled leucine, evaluate Ab synthesis and clearance in humans. This approach has an enormous potential to study the metabolism of proteins within the human CNS and consequently help in the understanding and diagnosis of neurological disorders.The main objective of this program is set up a targeted quantitative mass spectrometry method for existing and stable isotope-labelled CSF biomarkers in the neurological field; exploit this approach for diagnostic purpurses and to gain knowledge in the pathophysiology of diseases.

NCT ID: NCT01973764 Terminated - Hydrocephalus Clinical Trials

Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System

In-Vent
Start date: November 2013
Phase: N/A
Study type: Interventional

Puncture of the ventricular system is one of the most frequently performed neurosurgical interventions. This procedure is commonly performed in order to treat and/or measure pathologically elevated intracranial pressure.Therefore a safe and fast surgical procedure is needed. Currently the "landmark-based" placement of intraventricular catheters is the gold standard. However it is known that more than 60% of the catheters are not accurately placed in accordance with "landmark-based" procedures. When the catheter is not placed accurately multiple punctures may be required. In this study, the investigators aim to investigate prospectively whether ultrasound guidance leads to a lower number of incorrect catheter placements, and whether this guidance consequently decreases the number of punctures.

NCT ID: NCT01863381 Terminated - Hydrocephalus Clinical Trials

Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement

Start date: September 2014
Phase: N/A
Study type: Interventional

This research is being done to determine the accuracy of two noninvasive methods of measuring the pressure of the cerebrospinal fluid (CSF), also known as intracranial pressure or ICP.

NCT ID: NCT01863329 Terminated - Hydrocephalus Clinical Trials

Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasound Before and After Drainage of Cerebrospinal Fluid in Patient With Hydrocephalus

Start date: March 2013
Phase:
Study type: Observational

Studies in patients with intracranial hypertension have shown a good relationship between optic nerve sheath diameter measured by retrobulbar ultrasound and invasively measured intracranial pressure. The aim of this study was to evaluate changes in optic nerve sheath diameter before and after drainage of cerebrospinal fluid in patients with hydrocephalus.

NCT ID: NCT01834625 Terminated - Clinical trials for Normal Pressure Hydrocephalus Patients

Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement

Start date: April 2013
Phase:
Study type: Observational

In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long term (1 year). The imaging agent will be provided by AVID. Furthermore the study will standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden.

NCT ID: NCT01675037 Terminated - Clinical trials for Obstructive Hydrocephalus

Hypothalamic-pituitary Effects After Endoscopic Third Ventriculostomy

Start date: July 2012
Phase: N/A
Study type: Observational

Background: Endoscopic third ventriculostomy (ETV) is a standard procedure for the treatment of obstructive hydrocephalus in children and adults. Perforation of the third ventricle floor which is part of the hypothalamic-pituitary neuronal network is the key of this surgical procedure. Purpose: There are no prospective data available about the endocrine effects after ETV in children and adults. The principal aim of this prospective study is to evaluate the variability of hypothalamic-pituitary hormones and clinical effects in children and adults after ETV in order to plan a multicentric study.

NCT ID: NCT01191307 Terminated - Epilepsy Clinical Trials

Assess Specific Kinds of Children Challenges for Neurologic Devices Study

Start date: March 2009
Phase: N/A
Study type: Observational

The ASK CHILDREN study is intended to aid in future development of various neurologic devices (i.e. neuroprostheses). The ASK CHILDREN study seeks to use study information obtained to identify more efficient strategies in the evaluation and review of neuroprostheses regulated by the Agency.

NCT ID: NCT01092546 Terminated - Clinical trials for Normal Pressure Hydrocephalus

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Start date: March 2010
Phase: Phase 3
Study type: Interventional

To determine the level of association between the quantitative estimates of brain uptake of [18F]flutemetamol and the quantitative immunohistochemical and histochemistry estimates of amyloid levels in frontal lobe biopsy samples obtained from subjects during shunt placement for NPH.

NCT ID: NCT00946127 Terminated - Hydrocephalus Clinical Trials

ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus

Start date: March 2009
Phase: Phase 3
Study type: Observational

The purpose of this study is to test and compare the efficacy of Endoscopic Third Ventriculostomy with shunting of Cerebrospinal fluid (CSF)for treatment for patients of Normal pressure Hydrocephalus.

NCT ID: NCT00727142 Terminated - Clinical trials for Normal Pressure Hydrocephalus

Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus (INPH)

Start date: July 2008
Phase: N/A
Study type: Interventional

This study aims to provide class 1 evidence supporting or refuting the existence of normal pressure hydrocephalus.